Gld2 activity is regulated by phosphorylation in the N-terminal domain

References

• Paul P, Chakraborty A, Sarkar D, et al. Interplay between miRNAs and human diseases. J Cell Physiol. 2018;233:2007–2018.
   PubMed Web of Science ®Google Scholar
• De Almeida C, Scheer H, Zuber H, et al. RNA uridylation: a key posttranscriptional modification shaping the coding and noncoding transcriptome. Wiley Interdiscip Rev RNA. 2018;9:e1440.
   PubMed Web of Science ®Google Scholar
• Chung CZ, Seidl LE, Mann MR, et al. Tipping the balance of RNA stability by 3ʹ editing of the transcriptome. Biochim Biophys Acta. 2017;1861:2971–2979.
   PubMed Web of Science ®Google Scholar
• D’Ambrogio A, Gu W, Udagawa T, et al. Specific miRNA Stabilization by Gld2-catalyzed Monoadenylation. Cell Rep. 2012;2:1537–1545.
   PubMed Web of Science ®Google Scholar
• Jones MR, Blahna MT, Kozlowski E, et al. Zcchc11 uridylates mature miRNAs to enhance neonatal IGF-1 expression, growth, and survival. PLoS Genet. 2012;8:e1003105.
   PubMed Web of Science ®Google Scholar
• Jones MR, Quinton LJ, Blahna MT, et al. Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat Cell Biol. 2009;11:1157–1163.
   PubMed Web of Science ®Google Scholar
• Heo I, Ha M, Lim J, et al. Mono-uridylation of pre-microRNA as a key step in the biogenesis of group II let-7 microRNAs. Cell. 2012;151:521–532.
   PubMed Web of Science ®Google Scholar
• Winter J, Jung S, Keller S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11:228–234.
   PubMed Web of Science ®Google Scholar
• Kadyk LC, Kimble J. Genetic regulation of entry into meiosis in Caenorhabditis elegans. Dev Camb Engl. 1998;125:1803–1813.
   PubMed Web of Science ®Google Scholar
• Wang L, Eckmann CR, Kadyk LC, et al. A regulatory cytoplasmic poly(A) polymerase in Caenorhabditis elegans. Nature. 2002;419:312–316.
   PubMed Web of Science ®Google Scholar
• Katoh T, Sakaguchi Y, Miyauchi K, et al. Selective stabilization of mammalian microRNAs by 3ʹ adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev. 2009;23:433–438.
   PubMed Web of Science ®Google Scholar
• Glahder JA, Norrild B. Involvement of hGLD-2 in cytoplasmic polyadenylation of human p53 mRNA. APMIS. 2011;119:769–775.
   PubMed Web of Science ®Google Scholar
• Nousch M, Minasaki R, Eckmann CR. Polyadenylation is the key aspect of GLD-2 function in C. elegans. Rna N Y N. 2017;23:1180–1187.
   PubMed Web of Science ®Google Scholar
• Chung CZ, Jo DHS, Heinemann IU. Nucleotide specificity of the human terminal nucleotidyltransferase Gld2 (TUT2). Rna N Y N. 2016;22:1239–1249.
   PubMed Web of Science ®Google Scholar
• Nakel K, Bonneau F, Eckmann CR, et al. Structural basis for the activation of the C. elegans noncanonical cytoplasmic poly(A)-polymerase GLD-2 by GLD-3. Proc Natl Acad Sci U S A. 2015;112:8614–8619.
   PubMed Web of Science ®Google Scholar
• Bandiera S, Pfeffer S, Baumert TF, et al. miR-122–a key factor and therapeutic target in liver disease. J Hepatol. 2015;62:448–457.
   PubMed Web of Science ®Google Scholar
• Masaki T, Arend KC, Li Y, et al. miR-122 stimulates hepatitis C virus RNA synthesis by altering the balance of viral RNAs engaged in replication versus translation. Cell Host Microbe. 2015;17:217–228.
   PubMed Web of Science ®Google Scholar
• Kim G-W, Lee S-H, Cho H, et al. Hepatitis C Virus Core Protein Promotes miR-122 Destabilization by Inhibiting GLD-2. PLoS Pathog. 2016;12:e1005714.
   PubMed Web of Science ®Google Scholar
• Moriya K, Fujie H, Shintani Y, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med. 1998;4:1065–1067.
   PubMed Web of Science ®Google Scholar
• Dai R, Peng F, Xiao X, et al. Hepatitis B virus X protein-induced upregulation of CAT-1 stimulates proliferation and inhibits apoptosis in hepatocellular carcinoma cells. Oncotarget. 2017. DOI:10.18632/oncotarget.17631.
   Google Scholar
• Chang J, Nicolas E, Marks D, et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 2004;1:106–113.
   PubMedGoogle Scholar
• Peng F, Xiao X, Jiang Y, et al. HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122. PloS One. 2014;9:e92998.
   PubMed Web of Science ®Google Scholar
• Gebert LFR, Rebhan MAE, Crivelli SEM, et al. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res. 2014;42:609–621.
   PubMed Web of Science ®Google Scholar
• Van der Ree MH, van der Meer AJ, van Nuenen AC, et al. Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma. Aliment Pharmacol Ther. 2016;43:102–113.
   PubMed Web of Science ®Google Scholar
• Janssen HLA, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013;368:1685–1694.
   PubMed Web of Science ®Google Scholar
• Iino I, Kikuchi H, Miyazaki S, et al. Effect of miR-122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis. Cancer Sci. 2013;104:624–630.
   PubMed Web of Science ®Google Scholar
• Hirose Y, Ohkuma Y. Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression. J Biochem (Tokyo). 2007;141:601–608.
   PubMed Web of Science ®Google Scholar
• Mohan N, Ap S, Francis N, et al. Phosphorylation regulates the Star-PAP-PIPKIα interaction and directs specificity toward mRNA targets. Nucleic Acids Res. 2015;43:7005–7020.
   PubMed Web of Science ®Google Scholar
• Mertins P, Mani DR, Ruggles KV, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016;534:55–62.
   PubMed Web of Science ®Google Scholar
• Mertins P, Yang F, Liu T, et al. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics MCP. 2014;13:1690–1704.
   PubMed Web of Science ®Google Scholar
• Kettenbach AN, Schweppe DK, Faherty BK, et al. Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011;4:rs5.
   PubMed Web of Science ®Google Scholar
• Francavilla C, Papetti M, Rigbolt KTG, et al. Multilayered proteomics reveals molecular switches dictating ligand-dependent EGFR trafficking. Nat Struct Mol Biol. 2016;23:608–618.
   PubMed Web of Science ®Google Scholar
• Edelheit O, Hanukoglu A, Hanukoglu I. Simple and efficient site-directed mutagenesis using two single-primer reactions in parallel to generate mutants for protein structure-function studies. BMC Biotechnol. 2009;9:61.
   PubMed Web of Science ®Google Scholar
• Amanchy R, Tian XC, Kubota C, et al. A curated compendium of phosphorylation motifs. Nat Biotechnol. 2007;25:285–286.
   PubMed Web of Science ®Google Scholar
• Xue Y, Ren J, Gao X, et al. GPS 2.0, a Tool to Predict Kinase-specific Phosphorylation Sites in Hierarchy. Mol Cell Proteomics MCP. 2008;7:1598–1608.
   PubMed Web of Science ®Google Scholar
• Balasuriya N, Kunkel MT, Liu X, et al. Genetic code expansion and live cell imaging reveal that Thr308 phosphorylation is irreplaceable and sufficient for Akt1 activity. J Biol Chem. 2018;293:10744–10756.
   PubMed Web of Science ®Google Scholar
• Lee RS, House CM, Cristiano BE, et al. Relative Expression Levels Rather Than Specific Activity Plays the Major Role in Determining In Vivo AKT Isoform Substrate Specificity. Enzyme Res. 2011;2011:720985.
   PubMedGoogle Scholar
• Schmidt M-J, Norbury CJ. Polyadenylation and beyond: emerging roles for noncanonical poly(A) polymerases. Wiley Interdiscip Rev RNA. 2010;1:142–151.
   PubMed Web of Science ®Google Scholar
• Munoz-Tello P, Gabus C, Thore S. Functional implications from the Cid1 poly(U) polymerase crystal structure. Struct Lond Engl 1993. 2012;20:977–986.
   Google Scholar
• Chung CZ, Jaramillo JE, Ellis MJ, et al. RNA surveillance by uridylation dependent RNA decay in Schizosaccharomyces pombe. Nucleic Acids Res. 2019;47:3045–3057.
   Web of Science ®Google Scholar
• Rissland OS, Mikulasova A, Norbury CJ. Efficient RNA polyuridylation by noncanonical poly(A) polymerases. Mol Cell Biol. 2007;27:3612–3624.
   PubMed Web of Science ®Google Scholar
• Yates LA, Amode MR, Barrell D, et al. Structural plasticity of Cid1 provides a basis for its distributive RNA terminal uridylyl transferase activity. Nucleic Acids Res. 2015;43:2968–2979.
   PubMed Web of Science ®Google Scholar
• Lunde BM, Magler I, Meinhart A. Crystal structures of the Cid1 poly (U) polymerase reveal the mechanism for UTP selectivity. Nucleic Acids Res. 2012;40:9815–9824.
   PubMed Web of Science ®Google Scholar
• Nakel K, Bonneau F, Basquin C, et al. Structural basis for the antagonistic roles of RNP-8 and GLD-3 in GLD-2 poly(A)-polymerase activity. Rna N Y N. 2016;22:1139–1145.
   PubMed Web of Science ®Google Scholar
• Faehnle CR, Walleshauser J, Joshua-Tor L. Multi-domain utilization by TUT4 and TUT7 in control of let-7 biogenesis. Nat Struct Mol Biol. 2017;24:658–665.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Takagi Y, Nagaike T, et al. Crystal structures of U6 snRNA-specific terminal uridylyltransferase. Nat Commun. 2017;8:15788.
   PubMed Web of Science ®Google Scholar
• Maitra A, Shulgina I, Hernandez VJ. Conversion of active promoter-RNA polymerase complexes into inactive promoter bound complexes in E. coli by the transcription effector, ppGpp. Mol Cell. 2005;17:817–829.
   PubMed Web of Science ®Google Scholar
• Phatnani HP, Greenleaf AL. Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 2006;20:2922–2936.
   PubMed Web of Science ®Google Scholar
• Barnard DC, Ryan K, Manley JL, et al. Symplekin and xGLD-2 are required for CPEB-mediated cytoplasmic polyadenylation. Cell. 2004;119:641–651.
   PubMed Web of Science ®Google Scholar
• Kim JH, Richter JD. Opposing polymerase-deadenylase activities regulate cytoplasmic polyadenylation. Mol Cell. 2006;24:173–183.
   PubMed Web of Science ®Google Scholar
• Rouhana L, Wang L, Buter N, et al. Vertebrate GLD2 poly(A) polymerases in the germline and the brain. Rna N Y N. 2005;11:1117–1130.
   PubMed Web of Science ®Google Scholar
• Yamagishi R, Tsusaka T, Mitsunaga H, et al. The STAR protein QKI-7 recruits PAPD4 to regulate post-transcriptional polyadenylation of target mRNAs. Nucleic Acids Res. 2016;44:2475–2490.
   PubMed Web of Science ®Google Scholar
• Pearce LR, Komander D, Alessi DR. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol. 2010;11:9–22.
   PubMed Web of Science ®Google Scholar
• Menon B, Sinden J, Franzo-Romain M, et al. Regulation of LH receptor mRNA binding protein by miR-122 in rat ovaries. Endocrinology. 2013;154:4826–4834.
   PubMed Web of Science ®Google Scholar
• Yamada S, Tsukamoto S, Huang Y, et al. Epigallocatechin-3-O-gallate up-regulates microRNA-let-7b expression by activating 67-kDa laminin receptor signaling in melanoma cells. Sci Rep. 2016;6:19225.
   PubMed Web of Science ®Google Scholar
• Agarwal E, Brattain MG, Chowdhury S. Cell Survival and Metastasis Regulation by Akt Signalling in Colorectal Cancer. Cell Signal. 2013;25:1711–1719.
   PubMed Web of Science ®Google Scholar
• Spencer A, Yoon SS, Harrison SJ, et al. The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma. Blood. 2014;124:2190–2195.
   PubMed Web of Science ®Google Scholar
• Oh WJ, Wu CC, Kim SJ, et al. mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. Embo J. 2010;29:3939–3951.
   PubMed Web of Science ®Google Scholar
• Yao J, Zhang P, Li J, et al. MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1. Oncol Lett. 2017;14:1097–1104.
   PubMed Web of Science ®Google Scholar
• Ru N, Zhang F, Liang J, et al. MiR-564 is down-regulated in osteosarcoma and inhibits the proliferation of osteosarcoma cells via targeting Akt. Gene. 2018;645:163–169.
   PubMed Web of Science ®Google Scholar
• Sun H, Ding C, Zhang H, et al. Let‑7 miRNAs sensitize breast cancer stem cells to radiation‑induced repression through inhibition of the cyclin D1/Akt1/Wnt1 signaling pathway. Mol Med Rep. 2016;14:3285–3292.
   PubMed Web of Science ®Google Scholar
• Lian J-H, Wang W-H, Wang J-Q, et al. MicroRNA-122 promotes proliferation, invasion and migration of renal cell carcinoma cells through the PI3K/Akt signaling pathway. Asian Pac J Cancer Prev APJCP. 2013;14:5017–5021.
   PubMedGoogle Scholar
• Blahna MT, Hata A. Regulation of miRNA biogenesis as an integrated component of growth factor signaling. Curr Opin Cell Biol. 2013;25:233–240.
   PubMed Web of Science ®Google Scholar
• Manning BD, Toker A. AKT/PKB Signaling: navigating the Network. Cell. 2017;169:381–405.
   PubMed Web of Science ®Google Scholar
• Caretta A, Mucignat-Caretta C. Protein Kinase A in Cancer. Cancers (Basel). 2011;3:913–926.
   PubMedGoogle Scholar
• Johnson  SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell. 2005;120:635–647.
   PubMed Web of Science ®Google Scholar
• Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007;129:1261–1274.
   PubMed Web of Science ®Google Scholar
• Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–1797.
   PubMed Web of Science ®Google Scholar
• Roberts E, Eargle J, Wright D, et al. MultiSeq: unifying sequence and structure data for evolutionary analysis. BMC Bioinformatics. 2006;7:382.
   PubMed Web of Science ®Google Scholar
• Veidenberg A, Medlar A, Löytynoja A. Wasabi: an Integrated Platform for Evolutionary Sequence Analysis and Data Visualization. Mol Biol Evol. 2016;33:1126–1130.
   PubMed Web of Science ®Google Scholar
• Balasuriya N, McKenna M, Liu X, et al. Phosphorylation-Dependent Inhibition of Akt1. Genes (Basel). 2018;9:450.
   PubMed Web of Science ®Google Scholar
• Turk MA, Chung CZ, Manni E, et al. MiRAR-miRNA Activity Reporter for Living Cells. Genes (Basel). 2018;9:305.
   PubMed Web of Science ®Google Scholar
• MacLean B, Tomazela DM, Shulman N, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinforma Oxf Engl. 2010;26:966–968.
   PubMed Web of Science ®Google Scholar